SC: Menstrual Health is a Fundamental Right under Article 21; Orders Free Sanitary Pads in Schools  ||  Supreme Court: Industrial Court is the Proper Forum to Decide Issues Relating to Contract Labour  ||  Supreme Court: Only Civil Court of Original Jurisdiction Can Extend Arbitral Tribunal’s Mandate  ||  SC: Demolition of Private Property Must Rest on Clear Statutory Grounds and Due Consideration  ||  SC: After Complaint Was Withdrawn, BCI Disciplinary Committee Could Not Penalise Advocate  ||  MP HC: Decree Holder Cannot Defeat Compromise or Initiate Execution by Refusing Debtor’s Cheque  ||  MP HC: Spouse’s Income Cannot Be Clubbed With Public Servant’s for Disproportionate Assets Case  ||  Ker HC: Bar Association is Not Employer & Cannot Form Internal Complaints Committee under POSH Act  ||  SC: Ex-Contract Workers Must Be Preferred When Employers Replace Contract Labour With Regular Staff  ||  SC: Waqf Tribunals Cannot Hear Claims over Properties Not Listed or Registered under Waqf Act    

DGFT Changes Export Policy of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients - (15 Jun 2021)

CIVIL

Director-General of Foreign Trade (DGFT) has notified the changes in the Export policy of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients from ‘Prohibited’ to ‘Restricted’. Further, export of Injection Remdesivir and Remdesivir API against Advance Authorizations issued under Chapter 4 of Foreign Trade Policy/Handbook of Procedures shall not require separate export authorization or permission.

Tags : DIRECTOR-GENERAL OF FOREIGN TRADE   EXPORT POLICY OF INJECTION REMDESIVIR AND REMDESIVIR ACTIVE PHARMACEUTICAL INGREDIENTS  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved